FDA notifications.  Zidovudine approved for pediatric use.
D002648:Child; D017277:Drug Approval / Q000331:legislation & jurisprudence; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013607:Tablets; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine / Q000627:therapeutic use*
D018894:Reverse Transcriptase Inhibitors; D013607:Tablets; D015215:Zidovudine